Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Diluted EPS of $0.15 per share for fiscal year 2025.
IRONWOOD PHARMACEUTICALS INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.15 | +1400.0% |
| 2024 | $0.01 | +100.2% |
| 2023 | -$6.45 | -771.9% |
| 2022 | $0.96 | -70.1% |
| 2021 | $3.21 | +386.4% |
| 2020 | $0.66 | +371.4% |
| 2019 | $0.14 | +107.6% |
| 2018 | -$1.85 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.23 | +1050.0% | +64.3% |
| June 30, 2025 | $0.14 | +1500.0% | +160.9% |
| March 31, 2025 | -$0.23 | -666.7% | -1250.0% |
| September 30, 2024 | $0.02 | -77.8% | +300.0% |
| June 30, 2024 | -$0.01 | +99.9% | +66.7% |
| March 31, 2024 | -$0.03 | -112.0% | -133.3% |
| September 30, 2023 | $0.09 | -67.9% | +101.3% |
| June 30, 2023 | -$6.84 | -3357.1% | -2836.0% |
- IRONWOOD PHARMACEUTICALS INC showed an increase of +1400.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2018–2025 period, IRONWOOD PHARMACEUTICALS INC’s diluted eps has grown by 108.1% (from $1.85 per share (loss) to $0.15 per share).
- The most recent figure is from IRONWOOD PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: